Cytek Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer Busque Philippe
Cytek Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer Barnett Valerie
Cytek Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer Jiang Wenbin
Cytek Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer Poirson Allen
Cytek Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer Yan Ming
Cytek Biosciences | 4: Statement of changes in beneficial ownership of securities-Director Holder Michael
Cytek Biosciences | SC 13G: Statement of acquisition of beneficial ownership by individuals-Hillhouse Investment Management, Ltd.(5.1%)
Cytek Biosciences | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Brown Capital Management, LLC(7.22%)
Cytek Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer Jiang Wenbin
Cytek Biosciences | 4: Statement of changes in beneficial ownership of securities-Director Holder Michael
Cytek Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer Barnett Valerie
Cytek Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer Jiang Wenbin
Cytek Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer Yan Ming
Cytek Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer Williams Paul Christopher
Cytek Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer Poirson Allen
Cytek Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer Busque Philippe
Cytek Biosciences | 4: Statement of changes in beneficial ownership of securities-Director Holder Michael
Cytek Biosciences | 3: Initial statement of beneficial ownership of securities-Director Holder Michael
Cytek Biosciences | 4: Statement of changes in beneficial ownership of securities-Director Ball Jack
Cytek Biosciences | 4: Statement of changes in beneficial ownership of securities-Director NEFF DEBORAH J